Argitalpenak (181) Jesús Francisco Bermejo Martín argitalpenak Ikerketa datu erreferentziatuak ikusi.

2024

  1. Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients

    Intensive Care Medicine, Vol. 50, Núm. 11, pp. 1884-1896

  2. Influence of lymphopenia on long-term mortality in septic shock, a retrospective observational study

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 71, Núm. 5, pp. 368-378

  3. Prevalence and clinical relevance of viraemia in viral respiratory tract infections: a systematic review

    The Lancet Microbe

  4. Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine

    The Lancet Respiratory Medicine, Vol. 12, Núm. 4, pp. 305-322

  5. Quantification of bacterial DNA in blood using droplet digital PCR: a pilot study

    Diagnostic Microbiology and Infectious Disease, Vol. 108, Núm. 1

  6. Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19

    International Journal of Infectious Diseases, Vol. 140, pp. 132-135

  7. Synergistic impact of innate immunity hyper-activation and endothelial dysfunction on the magnitude of organ failure in the infection-sepsis continuum

    International Journal of Infectious Diseases, Vol. 146

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia

    International Journal of Infectious Diseases, Vol. 134, pp. 126-132

  3. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  4. Model-interpreted outcomes of artificial neural networks classifying immune biomarkers associated with severe infections in ICU

    Frontiers in Immunology, Vol. 14

  5. Prime-time for clinical use of transcriptomics for differentiating viral from bacterial respiratory infection

    European Journal of Clinical Investigation

  6. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

  7. Relationship between the structure, function and endothelial damage, and vascular ageing and the biopsychological situation in adults diagnosed with persistent COVID (BioICOPER study). A research protocol of a cross-sectional study

    Frontiers in Physiology, Vol. 14

  8. Transcriptomics reveals shared immunosuppressive landscapes in ventilator-associated lower respiratory tract infections (VA-LRTI) patients

    Expert Review of Anti-Infective Therapy, Vol. 21, Núm. 10, pp. 1135-1141

2022

  1. Alpha, Beta, Delta, Omicron, and SARS-CoV-2 Breakthrough Cases: Defining Immunological Mechanisms for Vaccine Waning and Vaccine-Variant Mismatch

    Frontiers in Virology, Vol. 2

  2. Bronchial Aspirate-Based Profiling Identifies MicroRNA Signatures Associated With COVID-19 and Fatal Disease in Critically Ill Patients

    Frontiers in Medicine, Vol. 8

  3. Digital PCR applications for the diagnosis and management of infection in critical care medicine

    Critical Care, Vol. 26, Núm. 1

  4. Evaluation of Respiratory Sequelae in Patients With COVID-19, Where we are and Where we are Going. CIBERESUCICOVID and RECOVID Studies to Compare Patients Admitted to ICU vs Conventional Ward

    Archivos de Bronconeumologia

  5. Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection

    Biomedicine and Pharmacotherapy, Vol. 154